Position in ACRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,324,738
+$2,439,872 QoQ
Shares Held
817,531
+62.7% QoQ
Ownership
0.555%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ACRS ranks #90 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ACRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,324,738 | 817,531 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,884,866 | 502,631 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,387,246 | 1,125,331 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,077,488 | 1,619,731 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,079,984 | 1,464,778 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,455,632 | 951,394 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,109,287 | 850,519 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,576,305 | 1,370,700 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,014,420 | 922,200 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,075,016 | 1,673,400 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,833,753 | 1,746,432 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,436,416 | 647,652 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,054,254 | 969,552 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $10,129,909 | 1,252,152 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,667,594 | 1,121,752 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $18,654,701 | 1,185,178 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,562,304 | 1,329,678 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $25,128,644 | 1,457,578 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $24,381,806 | 1,676,878 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $36,375,804 | 2,020,878 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $42,703,777 | 2,431,878 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $75,259,245 | 2,986,478 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $21,145,111 | 3,268,178 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $8,823,812 | 3,433,390 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,313,340 | 3,279,840 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,302,661 | 3,175,636 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||